NOTICE TO DISREGARD — ICARO Media Group
NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- We are advised by…
TScan Therapeutics Announces Positive Updated Data from the ALLOHA Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition
December 06, 2025 17:30 ET Â | Source: TScan Therapeutics, Inc. Treatment arm…
Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
December 06, 2025 17:30 ET  | Source: Fulcrum Therapeutics, Inc. ― Clear…
RadiantVibe Capital Consortium Debuts Insight Access Dashboard as Part of Ambrose Wetherbys Transparency Initiative
New York, NY, Dec. 06, 2025 (GLOBE NEWSWIRE) -- RadiantVibe Capital Consortium…
BI DeFi Launches New Daily Yield Plan as Demand for Accessible Crypto Income Solutions Grows
New York, USA, Dec. 06, 2025 (GLOBE NEWSWIRE) -- BI DeFi has…
Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients
Long-term OS follow-up analysis of JUPITER-02 demonstrates significantly better and clinically meaningful…
Cerevance Showcases Positive Phase 2 Results Demonstrating Significant Reduction in OFF Time with Solengepras as an Adjunctive Treatment in Parkinsons Disease
December 05, 2025 21:00 ET Â | Source: Cerevance, Inc. Phase 2 results…
Rocket Doctor Announces Granting of RSUs and Options and a Change of CFO
December 05, 2025 17:00 ET Â | Source: Rocket Doctor AI Inc. Vancouver,…
Global Mofy AI Limited Announces US$4.8 Million Private Placement Financing
BEIJING, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Global Mofy AI Limited (the…
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 05, 2025 08:00 ET Â | Source: UroGen Pharma Ltd. PRINCETON, N.J.,…